Pharma Giant
- All
- News
- Videos
-
Failure of AstraZeneca Trial Big Blow For Anti-Addiction Drugs: Report
The failure of the trial of the drug AZD4041 by pharma giant AstraZeneca, to combat opioid use disorder (OUD), highlights the challenges in developing non-opioid medications that treat addiction and withdrawal, according to a report.
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Couple Allege Daughter Died After Taking Covishield, To Sue AstraZeneca
The parents of a young woman who died allegedly after being given Covishield are planning to sue the world's largest vaccine maker and the British pharma giant that had developed the vaccine during the Covid pandemic.
-
No Side Effects From Our Vaccine: Covaxin Maker Amid AstraZeneca Row
The Covaxin was developed with a single-minded focus on safety first, said its maker Bharat Biotech on Thursday, days after British pharma giant AstraZeneca admitted that its Covid vaccine can cause rare side effects.
-
AstraZeneca Makes Big U-Turn, Admits Covishield Can Cause Rare Side Effects
British pharma giant AstraZeneca has admitted that its Covid vaccine can cause rare side effects, The Telegraph (UK) has reported.
-
Novartis Pharma Signs World's 1st Licensing Deal For Cancer Drug
Pharmaceutical giant Novartis has signed a licensing agreement increasing access to a vital leukaemia treatment, a UN-backed public health organisation said Thursday, marking the first-ever such agreement for a cancer drug.
-
Pharma Giant GSK Fires Employee After Video Of His Abusive Meltdown On Flight Goes Viral
A man in the United States was fired from his job after being caught on video yelling homophobic, racist slurs during a flight.
-
The Covid Pill For India: What We Know
Dr. D Srinivasa Reddy, CMD, Optimus Pharma Private Limited, spoke to NDTV today to explain the basics of the recently-cleared Covid pill for India. Molnupiravir has been licensed by US pharma giant Merck for over a dozen Indian firms.
-
Johnson And Johnson Sees New Allegations In Baby Powder Case
A lawyer for claimants suing Johnson & Johnson over its baby powder wants a bankruptcy judge to force the pharma giant to produce requested information, saying it's hindering efforts to investigate the case.
-
WHO Approves Novavax As 10th Authorised Covid Jab
The World Health Organization on Tuesday approved a Covid vaccine made by US pharma giant Novavax for emergency use, after the European Union medicines regulator gave it the green light.
-
US Pharma Giant Johnson & Johnson To Split Into 2 Companies
US pharmaceutical giant Johnson & Johnson on Friday announced plans to break up into two entities, turning its consumer health arm into a separate company.
-
Zydus Cadila Gets Final Approval From US FDA For Pre-Surgery Injection
India-based pharma giant, Zydus Cadila received final approval from US Food and Drug Administration (FDA) for Glycopyrrolate injection that is used before surgery to decrease the volume of secretions from the mouth, lungs and stomach.
-
The Era Of Anti-Covid Pills: What You Need To Know
US pharma giants Merck and Pfizer have announced encouraging results for oral aniviral pills, in what could open up a new chapter in the fight against the COVID-19 pandemic.
-
Failure of AstraZeneca Trial Big Blow For Anti-Addiction Drugs: Report
The failure of the trial of the drug AZD4041 by pharma giant AstraZeneca, to combat opioid use disorder (OUD), highlights the challenges in developing non-opioid medications that treat addiction and withdrawal, according to a report.
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Couple Allege Daughter Died After Taking Covishield, To Sue AstraZeneca
The parents of a young woman who died allegedly after being given Covishield are planning to sue the world's largest vaccine maker and the British pharma giant that had developed the vaccine during the Covid pandemic.
-
No Side Effects From Our Vaccine: Covaxin Maker Amid AstraZeneca Row
The Covaxin was developed with a single-minded focus on safety first, said its maker Bharat Biotech on Thursday, days after British pharma giant AstraZeneca admitted that its Covid vaccine can cause rare side effects.
-
AstraZeneca Makes Big U-Turn, Admits Covishield Can Cause Rare Side Effects
British pharma giant AstraZeneca has admitted that its Covid vaccine can cause rare side effects, The Telegraph (UK) has reported.
-
Novartis Pharma Signs World's 1st Licensing Deal For Cancer Drug
Pharmaceutical giant Novartis has signed a licensing agreement increasing access to a vital leukaemia treatment, a UN-backed public health organisation said Thursday, marking the first-ever such agreement for a cancer drug.
-
Pharma Giant GSK Fires Employee After Video Of His Abusive Meltdown On Flight Goes Viral
A man in the United States was fired from his job after being caught on video yelling homophobic, racist slurs during a flight.
-
The Covid Pill For India: What We Know
Dr. D Srinivasa Reddy, CMD, Optimus Pharma Private Limited, spoke to NDTV today to explain the basics of the recently-cleared Covid pill for India. Molnupiravir has been licensed by US pharma giant Merck for over a dozen Indian firms.
-
Johnson And Johnson Sees New Allegations In Baby Powder Case
A lawyer for claimants suing Johnson & Johnson over its baby powder wants a bankruptcy judge to force the pharma giant to produce requested information, saying it's hindering efforts to investigate the case.
-
WHO Approves Novavax As 10th Authorised Covid Jab
The World Health Organization on Tuesday approved a Covid vaccine made by US pharma giant Novavax for emergency use, after the European Union medicines regulator gave it the green light.
-
US Pharma Giant Johnson & Johnson To Split Into 2 Companies
US pharmaceutical giant Johnson & Johnson on Friday announced plans to break up into two entities, turning its consumer health arm into a separate company.
-
Zydus Cadila Gets Final Approval From US FDA For Pre-Surgery Injection
India-based pharma giant, Zydus Cadila received final approval from US Food and Drug Administration (FDA) for Glycopyrrolate injection that is used before surgery to decrease the volume of secretions from the mouth, lungs and stomach.
-
The Era Of Anti-Covid Pills: What You Need To Know
US pharma giants Merck and Pfizer have announced encouraging results for oral aniviral pills, in what could open up a new chapter in the fight against the COVID-19 pandemic.
